Patents by Inventor John Diener

John Diener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340058
    Abstract: The present disclosure provides relaxin-2 fusion protein analogs with enhanced in vivo half-life and methods for making the same. Also disclosed herein are methods of treating relaxin-2-associated disorders or diseases using the relaxin-2 fusion protein analogs described herein.
    Type: Application
    Filed: November 11, 2022
    Publication date: October 26, 2023
    Inventors: John DIENER, Andrew Kruse, Franz Gruswitz
  • Patent number: 10550391
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: February 4, 2020
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Publication number: 20180355362
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Application
    Filed: August 20, 2018
    Publication date: December 13, 2018
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Patent number: 10081811
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: September 25, 2018
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Publication number: 20170327829
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Patent number: 9752152
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating BetaENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: September 5, 2017
    Assignee: Arrowhead Pharmaceuticals, Inc.
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Publication number: 20160272979
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating BetaENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Application
    Filed: May 27, 2016
    Publication date: September 22, 2016
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Publication number: 20140182024
    Abstract: A new and distinctly salt and boron tolerant poplar tree cultivar named “RRR Yellow,” is particularly distinguishable by its ability to tolerate and grow in soil with high concentrations of salt, boron and selenium. The cultivar was originally discovered as a sport through stringent selection of cultivated poplar trees, and potentially from isolation of a single unique sapling or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the “RRR Yellow” cultivar.
    Type: Application
    Filed: December 26, 2012
    Publication date: June 26, 2014
    Inventors: Gary Banuelos, John Diener, James Prince
  • Patent number: 8598335
    Abstract: The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: December 3, 2013
    Assignee: Novartis AG
    Inventors: Antonin De Fougerolles, John Diener, Emma Hickman, Gregory Hinkle, Stuart Milstein, Anne-Marie Pulichino, Andrew Griffin Sprague
  • Patent number: 8598327
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to TFPI, which are useful as therapeutics in and diagnostics of bleeding disorders and/or other diseases or disorders in which TFPI has been implicated. In addition, the TFPI aptamers may be used before, during and/or after medical procedures to reduce complications or side effects thereof. The invention further relates to materials and methods for the administration of aptamers that bind to TFPI.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: December 3, 2013
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Robert Schaub, Kathleen McGinness, Jennifer Nelson, Ryan Genga, Emily Waters, Jeffrey Kurz, John Diener
  • Publication number: 20130254957
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named “Seleno-Orange,” is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the “Seleno-Orange” cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The “Seleno-Orange” cultivar has yellow flowers, mature green cladodes without glochids, and orange fruit.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 26, 2013
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Publication number: 20130254958
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named “Seleno-Purple,” is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the “Seleno-Purple” cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The “Seleno-Purple” cultivar has yellow flowers, mature green cladodes without glochids, and purple fruit.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 26, 2013
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Publication number: 20130254956
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named “Seleno-Green,” is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the “Seleno-Green” cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The “Seleno-Green” cultivar has yellow-orange flowers, mature green cladodes without glochids, and yellow-green fruit.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 26, 2013
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Publication number: 20130254959
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named “Seleno-Red,” is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the “Seleno-Red” cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The “Seleno-Red” cultivar has orange-red flowers, mature green cladodes without glochids, and red-purple fruit.
    Type: Application
    Filed: March 21, 2012
    Publication date: September 26, 2013
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Patent number: 8461318
    Abstract: The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to TFPI, which are useful as therapeutics in and diagnostics of bleeding disorders and/or other diseases or disorders in which TFPI has been implicated. In addition, the TFPI aptamers may be used before, during and/or after medical procedures to reduce complications or side effects thereof. The invention further relates to materials and methods for the administration of aptamers that bind to TFPI.
    Type: Grant
    Filed: November 3, 2011
    Date of Patent: June 11, 2013
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: Robert Schaub, Kathleen McGinness, Jennifer Nelson, Ryan Genga, Emily Waters, Jeffrey Kurz, John Diener
  • Patent number: PP24039
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named ‘Seleno-Orange’ is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the ‘Seleno-Orange’ cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The ‘Seleno-Orange’ cultivar has yellow flowers, mature green cladodes without glochids, and orange fruit.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: November 26, 2013
    Assignees: California State University, Fresno, Red Rock Ranch, LLC, USDA
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Patent number: PP24052
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named ‘Seleno-Red,’ is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the ‘Seleno-Red’ cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The ‘Seleno-Red’ cultivar has orange-red flowers, mature green cladodes without glochids, and red-purple fruit.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: December 3, 2013
    Assignees: California State University, Fresno, Red Rock Ranch, LLC, USDA
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Patent number: PP24053
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named ‘Seleno-Green,’ is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the ‘Seleno-Green’ cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The ‘Seleno-Green’ cultivar has yellow-orange flowers, mature green cladodes without glochids, and yellow-green fruit.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: December 3, 2013
    Assignees: California State University, Fresno, Red Roche Ranch, LLC, USDA
    Inventors: Gary Banuelos, John Diener, John Leonard Freeman
  • Patent number: PP24072
    Abstract: A new and distinctly salt and boron tolerant cultivar of prickly pear (Opuntia ficus-indica), named ‘Seleno-Purple,’ is particularly distinguishable by its ability to tolerate and grow in high concentration of salt, boron and selenium-laden soil. The cultigen was originally discovered by stringent selection of randomly harvested cladodes (modified stems) and potentially from isolation of a single unique cladode or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated into the ‘Seleno-Purple’ cultivar. The cladodes were originally randomly harvested from different individual plants and screened from within a naturally segregating wild population or accession. The ‘Seleno-Purple’ cultivar has yellow flowers, mature green cladodes without glochids, and purple fruit.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: December 10, 2013
    Assignees: California State University, Fresno, Red Rock Ranch, LLC, USDA
    Inventors: Gary Banuelos, John Leonard Freeman, John Diener
  • Patent number: PP26125
    Abstract: A new and distinctly salt and boron tolerant poplar tree cultivar named ‘RRR Yellow’, is particularly distinguishable by its ability to tolerate and grow in soil with high concentrations of salt, boron and selenium. The ‘RRR Yellow’ cultivar was originally discovered as a naturally occuring branch sport through stringent selection of cultivated poplar trees, and potentially from isolation of a single unique sapling or sport that exhibited high levels of salt and boron tolerance necessary for survival, and then propagated.
    Type: Grant
    Filed: December 26, 2012
    Date of Patent: November 24, 2015
    Assignees: California State University, Fresno, RedRock Ranch, USDA
    Inventors: Gary Banuelos, John Diener, James Prince